Working… Menu

Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL (LYMRIT-37-07)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03806179
Recruitment Status : Recruiting
First Posted : January 16, 2019
Last Update Posted : September 10, 2019
ICON Clinical Research
Information provided by (Responsible Party):
Nordic Nanovector